|
Formulary Forum is the first and only source for identifying the trends in formulary positioning of competing agents, understanding why those trends were taking place and predicting what changes lay ahead for brand positioning in the face of both patent expiries and new drug launches.
The new report series combines historical formulary data from Fingertip Formulary, which maintains the highest quality and most comprehensive, integrated database of formulary information in the United States, with a robust survey of 50 managed care organization pharmacy directors.
The pharmacy directors responses reveal what events triggered movement of key brands within their formulary for a specific disease as well as what moves they expect to make in formulary structure as new brands enter the market.
Now available
Formulary Advantages Among Monoclonal Antibodies in Oncology: Health Plans Report High Priority on Reducing Oncology Drug Costs
View the report abstract
Formulary Advantages in Multiple Sclerosis: How Will Price Impact the Uptake of Emerging Orally Delivered Therapies?
View the report abstract
Formulary Advantages Among Hepatitis C Virus Therapies: Pharmacy Directors Do Not Yet Understand the Pharmacoeconomic Incentives to Cover Emerging Therapies
View report abstract
Formulary Advantages in Parkinson's Disease Drugs: Which Clinical Endpoints Will Drive Uptake of Emerging Agents?
View report abstract
Formulary Advantages in Chronic Pain Therapies: How Will Price Impact the Coverage of Expensive Abuse-Deterrent Opioids and Biologics?
View report abstract
Formulary Advantages in Orally Delivered Oncology Agents: The Impact of Cost Controls and Emerging Agents on Key Brands
View report abstract
Formulary Advantages in Type 2 Diabetes: Impact of Current and Future DPP-IV Inhibitors and GLP-1 Analogues on Advantaged Reimbursement Status of Key Brands
View report abstract
Formulary Advantages in Osteoporosis: Rise and Fall of Access in the Wake of Fosamax Generics, Rebate and Contracting Efforts, and New Drug Launches
View report abstract
Formulary Advantages in Immune Biologics: Tightening Payer Control Offers Opportunities for Differentiation
View report abstract
Formulary Advantages in Hypertension: Past and Future Shifts in Tier Placement of Angiotension II Receptor Antagonists, Single Pill Fixed-Dose Combinations and Novel Agents
View report abstract
Contact us
For more information about Formulary Forum, e-mail us at sales@hl-isy.com.
|
Download more information about Formulary Forum
